Recombinant Human DPP9 Protein，His

Dipeptidyl peptidase 9 (DPP9) is a member of the prolyl oligopeptidase family, which plays a crucial role in various biological processes by regulating peptide substrates and modulating cellular signaling pathways. Recent studies have shown that DPP9 is involved in important physiological functions such as immune response, inflammation, and cell proliferation. Its dysregulation has been implicated in several diseases, including autoimmune disorders and cancer, making it a target of interest for therapeutic interventions. Additionally, DPP9 acts as an inhibitor of the activation of some immune pathways, and its unique substrate specificity offers insights into the regulatory mechanisms of cellular functions. The recombinant protein of DPP9 is utilized in various research applications, including biochemical assays, structural biology studies, and drug discovery efforts aimed at modulating its activity. Understanding the structure and function of DPP9 can provide valuable insights into its role in health and disease, offering potential avenues for novel therapeutic strategies. Given the increasing relevance of DPP9 in the context of disease pathology and treatment, the development and characterization of recombinant DPP9 proteins remains a critical area of research, enabling scientists to decipher its complex biological roles and establish its potential as a drug target.